What in the world would be the upside of CYDY playing dead and burning cash for 4 months when they could've partnered with a company that knows how to navigate the FDA? I say "none".

The end of June is not "fast approaching" as it is still 5 long weeks away. CYDY needs cash now, as is immediately and seems to have other trials on hold because they cannot pay for them. This WEAKENS the company's position, not strengthens. If there were partners ready to go, they wouldn't be wanting to wait for months and CYDY would be foolish to wait too, as that allows companies time to change their minds. As the saying goes, "Strike while the iron is hot" which is far different from "Sure the iron may be hot, but let's sit around and do nothing for 4 months and just collect a salary and announce a partnership when we feel like it." Again, what would the rationale be for just waiting until the end of June if a Gilead or Johnson and Johnson wanted to partner now? They can navigate the FDA, CYDY cannot.

IF and I say IF the NASH and tNBC results are so stellar and partners are ready to go, the people dying of these diseases need this drug now, not later as later will be, sadly, too late for some.